Cargando…
Low HDL-c levels at admission are associated with greater severity and worse clinical outcomes in patients with COVID-19 disease
BACKGROUND AND AIMS: HDL particles may act to buffer host cells from excessive inflammatory mediators. The aim of this study is to investigate if the lipid profile provides a prognostic biomarker for COVID-19 outcomes. METHODS: This was a prospective study of the characteristics of 125 adult COVID-1...
Autores principales: | Parra, Sandra, Saballs, Mireia, DiNubile, Mark, Feliu, Mireia, Iftimie, Simona, Revuelta, Laia, Pavón, Raul, Àvila, Alba, Levinson, Susan, Castro, Antoni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988188/ https://www.ncbi.nlm.nih.gov/pubmed/36910513 http://dx.doi.org/10.1016/j.athplu.2023.01.002 |
Ejemplares similares
-
Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 Pneumonia
por: DiNubile, Mark J, et al.
Publicado: (2022) -
HDL-c levels predict the presence of pleural effusion and the clinical outcome of community-acquired pneumonia
por: Saballs, M., et al.
Publicado: (2016) -
Plasma gelsolin as a biomarker of inflammation
por: DiNubile, Mark J
Publicado: (2008) -
Noninferior Antibiotics: When Is “Not Bad” “Good Enough”?
por: DiNubile, Mark J.
Publicado: (2016) -
Delayed Therapy with Plasma Gelsolin Improves Survival in Murine Pneumococcal Pneumonia
por: Yang, Zhiping, et al.
Publicado: (2017)